Latest News - Baxter
Top Corporates Hub
Baxter
Baxter International's Q2 2026 Earnings: What to Expect
08.07.2026 11:14
Baxter International will release its second-quarter earnings soon, and analysts anticipate a double-digit profit dip.
These S&P500 stocks are moving in today's pre-market session
07.07.2026 12:35
Pre-market stock analysis of S&P500 stocks on 2026-07-07: top gainers and losers in today's session.
3 Value Stocks We Keep Off Our Radar
07.07.2026 10:25
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
These S&P500 stocks are moving in today's session
02.07.2026 16:35
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform
18.06.2026 14:01
MediThinQ, a South Korea-based innovator in surgical visualization technologies, has entered into an exclusive multi-year distribution agreement with Synovis Micro Companies Alliance, Inc. ("Synovis MCA"), a subsidiary of Baxter International Inc. (NYSE:BAX) and trusted leader in microsurgical devices and solutions, to commercialize SHIYA, its 3D surgical visualization platform. Terms of this agreement were not disclosed.
Reasons to Retain Baxter International Stock in Your Portfolio for Now
16.06.2026 18:14
BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.
Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value Warranted
15.06.2026 01:11
Wondering whether Baxter International at US$20.86 is a bargain or a value trap? This article breaks down what the current share price might be telling you about the stock. The stock has risen 7.6% over the past week and 20.6% over the past month, yet is still down 7.0% year to date and has declined 31.3% over the last year. This raises questions about how the market now views its risk and potential. Recent coverage has focused on Baxter International's position within the medical equipment...
Baxter International (BAX) Faces Tough Road Ahead, Says Citi in Downgrade
10.06.2026 04:01
With a TTM operating cash flow of $1.25 billion, Baxter International Inc. (NYSE:BAX) is included among the 12 Cash-Rich Stocks to Buy Right Now. On May 28, Citi analyst Joanne Wuensch downgraded Baxter International Inc. (NYSE:BAX) to Sell from Neutral. She lowered the price target on the stock to $17 from $19. In a research note, the […]
FMS and Home Dialysis: How 5008X Could Reset Demand
08.06.2026 18:51
FMS scales 5008X high-volume HDF and expands home dialysis, aiming for benefits later in 2026 and a bigger payoff in 2027+.
Why Baxter (BAX) Shares Are Sliding Today
29.05.2026 00:38
Shares of healthcare company Baxter International (NYSE:BAX) fell 1% in the morning session after Citigroup downgraded the stock to Sell from Neutral and lowered its price target to $17.
Has Baxter International (BAX) Overreacted After Recent 10.9% Weekly Share Price Jump
24.05.2026 06:11
Wondering whether Baxter International at around US$19.18 is a bargain or a value trap? This article walks through what the current price might actually imply. The stock has moved sharply in the short term, with a 10.9% gain over the past week and 5.6% over the past month, despite being down 1.6% year to date and declining 35.5% over the past year and 50.2% over three years. These moves sit against an ongoing evergreen interest in Baxter International as a large healthcare equipment company...
1 Stock Under $50 Worth Investigating and 2 Facing Challenges
23.05.2026 14:44
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
22.05.2026 06:12
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Baxter (NYSE:BAX) and its peers.
Medical Adhesives Research and Forecast Report 2026-2035: $23+ Bn Market is Fiercely Competitive, Featuring Giants Like 3M Company, Avery Dennison, Baxter, Dow Chemical, H.B. Fuller, and Henkel
18.05.2026 14:31
The medical adhesives market is poised for growth driven by the rise in minimally invasive surgeries, demand for advanced wound care, and wearable tech. Key opportunities lie in developing smart, biocompatible, and eco-friendly options, especially in Asia, with a focus on internal medical applications and water-based technologies.Dublin, May 18, 2026 (GLOBE NEWSWIRE) -- The "Medical Adhesives Market, Till 2035: Distribution by Type of Resin, Type of Technology, Areas of Application, Type of Ente
First Pacific Advisors' Strategic Moves: Baxter International Inc. Takes Center Stage
14.05.2026 12:00
Exploring the Latest 13F Filing and Investment Strategies
Baxter International Stock Outlook: Is Wall Street Bullish or Bearish?
05.05.2026 03:37
As Baxter International has notably underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.
Barclays Maintains Overweight on Baxter International, Raises Price Target to $27
04.05.2026 10:23
Barclays analyst Matt Miksic maintains Baxter International (NYSE:BAX) with a Overweight and raises the price target from $25 to $27.
Assessing Baxter International (BAX) Valuation After Earnings Beat And Reaffirmed Outlook
03.05.2026 12:04
Baxter International (BAX) has drawn fresh attention after reporting first quarter 2026 results that topped Wall Street expectations on revenue and adjusted earnings, while reaffirming full year guidance despite a GAAP net loss. See our latest analysis for Baxter International. Despite the positive earnings surprise and reaffirmed outlook, Baxter’s 1 day share price return of a 2.1% decline and 7 day share price return of a 5.23% decline sit against a 1 year total shareholder return of a...
Baxter Profit Plunges 35% As Tariffs, Costs Bite
01.05.2026 07:54
Baxter tops earnings, but profit plunges 35% as tariffs and manufacturing costs rise; outlook for 2026 remains intact.